TABLE 11: Treatment - surgery

% of Cases treated with Surgery
Country average (population) Country average (country) England Scotland Northern Ireland Wales Republic of Ireland
All invasive xnmsc 48.9% 48.5% 49.5% 42.0% 54.0%
All xnmsc 0-24 52.1% 51.6% 52.1% 53.8% 48.9%
All xnmsc 25-59 66.9% 66.6% 67.4% 61.7% 70.6%
All xnmsc 60-79 48.4% 47.2% 49.1% 39.9% 52.6%
All xnmsc 80+ 30.5% 30.6% 31.0% 23.7% 37.1%
Haematology 6.2% 7.7% 6.1% 6.9% 10.2%
Head and Neck 53.9% 52.2% 54.9% 45.4% 56.4%
Lower GI 68.1% 69.1% 68.5% 60.7% 78.0%
Upper GI 36.2% 37.5% 37.7% 16.7% 58.0%
HPB 31.0% 29.5% 32.6% 10.3% 45.5%
Trachea, Bronchus & Lung 24.8% 22.0% 26.3% 13.2% 26.6%
Melanoma of skin 96.8% 95.1% 96.9% 97.4% 90.9%
Breast 77.8% 79.8% 77.8% 75.9% 85.6%
Cervix 64.3% 63.9% 65.3% 55.8% 70.7%
Other Female Genitals 75.3% 74.7% 75.7% 70.5% 77.8%
Prostate 22.3% 18.6% 23.0% 15.7% 17.0%
Kidney 60.7% 62.9% 61.0% 52.2% 75.5%
Bladder 85.4% 84.9% 86.1% 77.5% 91.0%
Brain and CNS 48.8% 51.0% 48.5% 50.8% 53.8%
Thyroid & other endocrine glands 87.8% 86.0% 88.4% 80.3% 89.3%
CUP 13.2% 12.5% 13.9% 5.1% 18.4%
Other invasive cancer 56.3% 53.7% 57.4% 47.0% 56.7%
Breast in situ 88.7% 88.6% 88.6% 91.5% 85.8%
Cervix in situ 86.8% 66.2% 88.7% 97.6% 12.4%
Other tumours 64.0% 61.9% 63.9% 70.6% 51.1%
Non-Melanoma Skin Cancer 42.2% 61.4% 37.4% 92.1% 54.7%